2024

A multicenter clinical trial has evaluated the efficacy and safety of extended antibiotic infusion in febrile neutropenia

Leave a Comment / Infections of the Respiratoy Tract and in Immunocompromised Patients , Infectious disease and transplantation Program / By

A Bellvitge research team has conducted a randomized clinical trial in hematological patients with febrile neutropenia to assess the efficacy of extended infusion of beta-lactam antibiotics

The results show that extended perfusion may be useful in combating some infections, but do not support the introduction of this technique into daily clinical practice for the empirical treatment of febrile neutropenia.

A multicenter clinical trial has evaluated the efficacy and safety of extended antibiotic infusion in febrile neutropenia Read More »

IDIBELL, Bellvitge Hospital and the Josep Carreras Institute discover a key mechanism in the recovery of kidney transplant function

Leave a Comment / Infectious disease and transplantation Program, Nephrology and renal transplantation, Translational Medicine Area / By

They have described a cause why kidney progenitor cells sometimes can’t repair damaged tissues
The study has been published in the American Journal of Transplantation, the journal with the highest impact on transplantation

IDIBELL, Bellvitge Hospital and the Josep Carreras Institute discover a key mechanism in the recovery of kidney transplant function Read More »

An intellectually stimulating lifestyle is key to fighting Huntington’s disease

Leave a Comment / Cognition and Brain Plasticity, Neuroscience Area, Neuroscience Program / By

An intellectually stimulating lifestyle has been shown to reduce the severity of cognitive deficits and delay disease progression in Huntington’s disease patients. Now, a new study led by IDIBELL researchers shows that these positive effects may also have a direct transfer to motor and psychiatric domains of the disease, not only cognitive.

An intellectually stimulating lifestyle is key to fighting Huntington’s disease Read More »

New advances in research on metastasis in different types of melanoma

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, TGF-beta and cancer / By

A team of researchers from IDIBELL presents two studies that expand knowledge about metastasis in melanoma.
They have managed to decipher, on the one hand, the role of PRRX1 in cancer progression and metastasis of cutaneous melanoma, as well as its prognostic value, and, secondly, the role of exosomes in the preparation of liver metastasis of uveal melanoma.

New advances in research on metastasis in different types of melanoma Read More »

Growth pattern in colon cancer liver metastases may influence response to immunotherapy

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Tumor and stromal chemoresistance  / By

IDIBELL and ICO researchers demonstrate that the better prognosis of colon cancer with encapsulating liver metastases is due to the characteristics of the cellular microenvironment.
The study indicates that encapsulating metastases have an antitumor immunity that could be exploited using immunotherapies.

Growth pattern in colon cancer liver metastases may influence response to immunotherapy Read More »

An international study with the participation of IDIBELL shows that the drug semaglutide, for obesity and diabetes, protects the kidney in obese people with kidney disease

Leave a Comment / Infectious disease and transplantation Program, Nephrology and renal transplantation, Translational Medicine Area / By

The novel results have been presented at the Kidney Week 2024 Congress of the American Society of Nephrology, in San Diego, and have been published simultaneously in the prestigious journal Nature Medicine. In Spain, 40% of the population is overweight, 22% of the population is obese and 3 out of 10 patients with chronic kidney disease suffer from obesity.

An international study with the participation of IDIBELL shows that the drug semaglutide, for obesity and diabetes, protects the kidney in obese people with kidney disease Read More »

According to a European survey, only 6 of every 10 Spanish houses are smoke-free

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Tobacco control research  / By

Seven out of ten homes in Europe are smoke-free, according to a major survey published today in ERJ Open Research.
In Romania, Bulgaria and Spain, more than four in ten homes allow smoking to take place, while England scored highest with more than eight in ten homes smoke-free.

According to a European survey, only 6 of every 10 Spanish houses are smoke-free Read More »

The second RegenBell Symposium on stem cells and regenerative medicine takes place

Leave a Comment / Regenerative Medicine Area, Regenerative Medicine Program / By

The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject. 11 conferences were presented, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.

The second RegenBell Symposium on stem cells and regenerative medicine takes place Read More »

Scroll to Top